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Dr. Jeffrey Koplan, Director of the Centers for Disease
Control and Prevention (CDC), has set four goals for the
agency to accomplish. Each is directly related to issues being
discussed at the 2000 ICEID conference. The first goal is to
strengthen the science base for public health action. The
second goal is to collaborate with healthcare partners for
disease prevention; it is essential that individuals in clinical
and academic medicine work closely with colleagues in public
health to address these issues. The third goal is to promote
healthy living for people at every stage of life. Finally, and very
importantly to participants in this conference, the fourth goal for
the agency is to work with partners to improve global health.
An article in Morbidity and Mortality Weekly Report in
1999 contains a summary of progress made in infectious
disease control in the United States during the 20th century
when the number of deaths resulting from infectious diseases
decreased dramatically (1). However, the dramatic spike in
the number of deaths from 1918 to 1919 resulting from the
first of three influenza pandemics, is clearly evident (Figure
1). In addition, the number of deaths caused by infectious
diseases increased between 1980 and 1995. Because of the
excellent progress made against infectious diseases during
much of the 20th century, many people felt that the problem
of infectious diseases had been sufficiently addressed. Nearly
40 years ago, Sir MacFarlane Burnett wrote, “One can think
of the middle of the twentieth century as the end of one of the
most important social revolutions in history, the virtual
elimination of the infectious disease as a significant factor in
social life” (2). This quotation reveals the complacency that has
existed since and goes a long way toward explaining why we have
gotten behind both nationally and globally in terms of capacity
required to deal with the problems of infectious diseases.
The current problems we face as a result were highlighted
in a very important 1992 Institute of Medicine (IOM) report,
Emerging Infections: Microbial Threats to Health in the
United States (3). This seminal work represents the effort of
an expert committee cochaired by Dr. Joshua Lederberg and
Dr. Robert Shope. This committee defined emerging infections as
“new, reemerging, or drug-resistant infections whose incidence
in humans has increased within the past two decades or whose
incidence threatens to increase in the near future.”
The committee also identified six major factors that
contribute to disease emergence and reemergence: 1) changes
in human demographics and behavior, 2) advances in
technology and changes in industry practices, 3) economic
development and changes in land-use patterns, 4) dramatic
increases in volume and speed of international travel and
commerce—movement not only of people but of animals,
foodstuffs, and other commodities, 5) microbial adaptation
and change (a factor that makes infectious diseases unique
and particularly challenging), and 6) breakdown of public
health capacity required for infectious diseases at the local,
state, national, and global levels. In most cases, more than
one of these factors are applicable to the emergence or
reemergence of an individual disease or syndrome.
The IOM report contains 15 recommendations, many of
which we felt were directed specifically to CDC. We responded
to that report by developing a CDC Emerging Infections Plan,
issued in 1994 (4), and an updated version, published in 1998
(5), that outlines a strategy for CDC to work with many
partners throughout the country and around the world to
address these issues. The plan contains four goals. The first
emphasizes the need to strengthen infectious disease
surveillance and response; this approach is necessary to
ensure timely detection and control of diseases and their
agents. Second, many research issues raised by these
challenges need to be addressed. Third, the public health
system is in urgent need of repair so that it can deal with these
issues; the CDC strategy emphasizes the training needs
associated with human resource development, an important
goal of this conference. The final, ultimate goal stresses the
need to strengthen prevention and control programs locally,
nationally, and globally.
This conference has several dominant themes. The first is
antimicrobial resistance. The IOM has maintained a strong
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Figure 1. Trends in Infectious Diseases Mortality, 1900-1996. Deaths
resulting from infectious diseases decreased markedly in the United
States during most of the 20th century. However, between 1980 and
1992, the death rate from infectious diseases increased 58%. The sharp
increase in infectious disease deaths in 1918 and 1919 was caused by an
influenza pandemic, which killed more than 20 million people.495 Vol. 7, No. 3 Supplement, June 2001 Emerging Infectious Diseases
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Figure 2. The National Molecular Subtyping Network for Foodborne Disease Surveillance.  Area Lab Service and Support Zones.
interest in emerging infectious disease control by recently
issuing a report by an ongoing forum on antimicrobial
resistance (6). Foodborne disease and food safety is another
prominent theme. A number of presentations include data
from a national surveillance network, the National Molecular
Subtyping Network for Foodborne Disease Surveillance
(PulseNet, Figure 2), which represents the vision for modern
infectious disease surveillance (7).
Electronic linkages of individuals at local, state, and
national levels who are utilizing modern molecular
epidemiologic techniques in public health laboratories are
absolutely essential to ensure the rapid identification of
emerging foodborne diseases. This approach needs to be
expanded beyond foodborne disease and linked with
healthcare facilities and clinical laboratories to integrate our
infectious disease surveillance systems. PulseNet represents
a partnership between CDC, the Food and Drug Administra-
tion, the U.S. Department of Agriculture, the Association of
Public Health Laboratories, and many individual state public
health laboratories throughout the country.
This conference also emphasizes the global nature and
scope of infectious diseases. Another recent IOM report
acknowledges this point and concludes, “Distinctions between
domestic and international health problems are losing their
usefulness and often are misleading” (8). Before 1999, West Nile
virus had never been found in the Western Hemisphere, though
it was a well-recognized cause of disease in Africa, Europe, and
the Middle East. Recent experience reinforces the need to
address not only surveillance of and capacity to respond to
vectorborne diseases, but also the importance of research on
infectious diseases that exist in other parts of the world.
In the 8 years since the IOM Emerging Infections report
was published, CDC has collaborated with Dr. David
Heymann and his colleagues at the World Health
Organization (WHO), along with many other individuals in
many countries around the world, to deal with a number of
infectious disease outbreaks. Lessons from this experience
consistently emphasize the importance of infectious disease
surveillance, the ability to rapidly conduct an epidemiologic
investigation, and the need for trained staff and modern
laboratory facilities to diagnose these diseases accurately and
rapidly. Many outbreaks have reminded us of the disruption
of travel and commerce that can occur when local outbreaks
have global implications.
The West Nile encephalitis outbreak reinforces these
lessons: that all of us need to keep an open mind about
possible causes of a particular infectious disease outbreak;
that clinicians and public health workers need to collaborate
closely; and that people involved in human medicine and
human public health need to interact on a more regular basis
with colleagues in veterinary medicine and veterinary public
health. State public health veterinarians have an important
role in this regard. The experience with West Nile
encephalitis also highlights the necessity of developing public496 Emerging Infectious Diseases Vol. 7, No. 3 Supplement, June 2001
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health laboratory capacity and of continuing to invest in
training of young people in disciplines such as entomology
and wildlife biology, and it also reveals a number of critical
communication issues that such outbreaks raise.
We have been very pleased during the past few years to
work with the Association of Public Health Laboratories to
increase CDC’s role in training public health laboratory
scientists. We have done this, in part, through an Emerging
Infectious Diseases Laboratory Fellowship Program that
initially had a domestic focus, but, with the support of Eli
Lilly and Company and the CDC Foundation, now includes an
international track to bring scientists from other countries to
work with us at CDC or with colleagues in state public health
department laboratories to acquire critical public health
laboratory skills.
The West Nile virus outbreak also provides a vivid
reminder that we need to consider the possibility that a
complex infectious disease outbreak may result from
bioterrorism. Preparing for this possibility will strengthen
the national and global ability to address emerging and
reemerging infections. In an address at the National Academy
of Sciences in 1999, President Clinton said, “These cutting
edge efforts (focused on bioterrorism preparedness) will
address not only the threat of weapons of mass destruction
but also the equally serious danger of emerging infectious
diseases” (9). The future is hard to predict, but we can be
pretty certain that we are going to continue to be challenged
by the problem of antimicrobial resistance. We will eventually
experience another influenza pandemic, and urban yellow
fever threatens to reemerge in Latin America. Recent
experience suggests that we will continue to need to deal
with regional, national, and global outbreaks of foodborne
disease. We are going to continue to be surprised by the
range of chronic diseases that have infectious causes.
Finally, we know that we are going to have to be prepared
to confront the unexpected.
The intelligence community has acknowledged that
infectious diseases represent a threat to national security
(10). Leaders of the Group of Eight Industrialized Nations
have made a commitment to substantially reduce the global
burden of HIV infection, tuberculosis, and malaria by 2010
(11). This conference provides a timely opportunity for CDC
and its many partners to examine lessons learned and review
our commitment to rebuild national and global public health
systems in order to address these three diseases as well as the
numerous challenges posed by other emerging infectious
diseases.
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